Stand:
Establishment Labs® Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on
improving patient safety and aesthetic outcomes, in the breast aesthetics and reconstruction market by
designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast
implants, branded as Motiva Implants®. Our latest technology, JOY.(dot), has recently been launched globally.
Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica, and have been
on the market, in over 80 countries, for more than a decade.
In March 2018, Establishment Labs® received approval for an investigational device exemption (IDE) from the
FDA to initiate the Motiva Implants® clinical trial in the United States. The four-year results have consistently
reported rates of less than 1 % device-related complications leading to reoperation.
show more
show less
Motiva Establishment Labs® Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on
improving patient safety and aesthetic outcomes, in the breast aesthetics and reconstruction market by
designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast
implants, branded as Motiva Implants®. Our latest technology, JOY.(dot), has recently been launched globally.
Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica, and have been
on the market, in over 80 countries, for more than a decade.
In March 2018, Establishment Labs® received approval for an investigational device exemption (IDE) from the
FDA to initiate the Motiva Implants® clinical trial in the United States. The four-year results have consistently
reported rates of less than 1 % device-related complications leading to reoperation.
